Pell Bio-Med Technology Co., Ltd. (6949) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Pell Bio-Med Technology Co., Ltd. (6949:TWSE), powered by AI.

Current Price
$895.00
Sector
Healthcare
What is the Pell Bio-Med Technology Co., Ltd. stock price forecast?

Pell Bio-Med Technology Co., Ltd. is currently trading at $895.00. View real-time AI analysis on Alpha Lenz.

What is Pell Bio-Med Technology Co., Ltd. insider trading activity?

View the latest insider trading data for Pell Bio-Med Technology Co., Ltd. on Alpha Lenz.

What is Pell Bio-Med Technology Co., Ltd.'s P/E ratio?

View Pell Bio-Med Technology Co., Ltd.'s valuation metrics on Alpha Lenz.

Pell Bio-Med Technology Co., Ltd.

TWSE · 6949
NT$895.00+81.00(+9.95%)
Ask about Pell Bio-Med Technology Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Pell Bio-Med Technology Co., Ltd.'s ROE is -32.6%. Explore profitability and growth together.

Ask for details

Company Overview

Pell Bio-Med Technology Co., Ltd. is a distinguished entity in the biotechnology and medical technology sectors. The company primarily focuses on the research, development, and manufacturing of advanced medical devices and diagnostic tools. Emphasizing innovation, Pell Bio-Med Technology Co., Ltd. creates cutting-edge solutions designed to address critical healthcare needs, including next-generation diagnostic systems and therapeutics. Serving a broad spectrum of the healthcare industry, the company's offerings are utilized in hospitals, clinical laboratories, and research institutions worldwide. Beyond its products, Pell Bio-Med invests heavily in research and development to stay at the forefront of technological advancements in health care. This commitment not only enhances their market position but also supports the broader medical community by offering tools that facilitate precise medical diagnostics and treatments. As a leader in its field, Pell Bio-Med Technology Co., Ltd. plays a pivotal role in advancing public health infrastructures and influencing trends in medical technology globally.

CEOMr. Cheng Long Lin
SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$31.42MRevenue
0.00Shares Out
0Employees

Margins

-13.97%Gross
-1284.08%EBITDA
-1487.24%Operating
-1440.53%Pre-Tax
-1440.53%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

22.35%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-23.47%ROA
-32.59%ROE
-23.37%ROIC

Financial Health

NT$306.70MCash & Cash Equivalents
NT$111.57MNet Debt
24.69%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Pell Bio-Med Technology Co., Ltd. (ticker: 6949) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 895 with a P/E ratio of -x and P/B of -x.

ROE is -32.59% and operating margin is -1487.24%. Annual revenue is $31M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Pell Bio-Med Technology Co., Ltd. (6949) Stock Forecast 2026 $895.00 — Price, Financials & Analyst Targets | Alpha Lenz